JNJ trade ideas
Johnson & Johnson earnings tomorrow at 6:40amJohnson & Johnson earnings are tomorrow at 6:40am. My range is low $157, mid $162, high $167.
4th Quarter December 2020
Consensus =
EPS: $1.81
Revenue: $21.73 Billion
Do your own due diligence, your risk is 100% your responsibility. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you double a penny a day for a month it = $5,368,709. Good luck and happy trading friends...
*3x lucky 7s of trading*
7pt Trading compass:
Price action, entry/exit
Volume average/direction
Trend, patterns, momentum
Newsworthy current events
Revenue
Earnings
Balance sheet
7 Common mistakes:
+5% portfolio trades, risk management
Beware of analysts motives
Emotions & Opinions
FOMO : bad timing
Lack of planning & discipline
Forgetting restraint
Obdurate repetitive errors, no adaptation
7 Important tools:
Trading View app!, Brokerage UI
Accurate indicators & settings
Wide screen monitor/s
Trading log (pencil & graph paper)
Big organized desk
Reading books, playing chess
Sorted watch-list
Checkout my indicators:
Fibonacci VIP - volume
Fibonacci MA7 - price
pi RSI - trend momentum
TTC - trend channel
www.tradingview.com
Ascending triangle breakout, record annual income projectedTextbook ascending triangle breakout. I took a look at net income as a sanity check, projected to be record setting. Swing trade, could drop back down to triangle top for retest, set stop below that. Price target is the height of the triangle above the triangle, hence a copy of the triangle being used as a reference. Set target below that to avoid psychological whole number resistance.
JNJ BullishJNJ is a federally subsidized company and is currently making new highs. It is in the S&P500, and has been a consistently bullish stock throughout times. Right now it is in the middle of an upwards move. JNJ is one of the companies that has been producing the COVID19 vaccine.
I hope you have a wonderful holiday I will see you all Tuesday
Easy bullish trend for Johnson & Johnson (JNJ)Fundamental Analysis.
1. Industry: Corona Vaccin ++
2. Price: Relatively Cheap
3. Upward potential: 20-40%
4. Risk-Reward Ratio: 1:10
Technical Analysis.
1. Volume is growing
2. Support of the MA30
4. Financial Morningstar Score: A
4. Growth rate: 93%
5. Short-term target: 180
6. Long term target: 200-
7. High Dividend Rate
Johnson & Johnson (JNJ)JNJ is well positioned for an interesting 2021 as COVID vaccine is a driver of growth and rebound in its Medical Devices Division should propel the stock price to new highs. Unlike the vaccines from Pfizer (PFE) and Moderna (MRNA), Johnson & Jonson's vaccine only calls for one dose in the treatment regimen. This stock offers worthwhile risk-adjusted, total return potential with a dividend yeld of 2.80%
JOHNSON & JOHNSON D1Johnson & Johnson Company is one of the largest hygiene products companies. The company's shares have recently reached historic highs. The global pandemic influenced this significantly. Because the company's products at that time were in great demand and the company received quite large profits, which became an incentive for the growth of the company's shares. But most likely this is not the limit and in the near future we will be able to see the next maximum. The situation with the corona virus does not end, but rather picks up a new wave. What the statistics say. And although vaccination has already begun in many countries, it is unlikely that this will quickly solve this problem. Thus, the company's products will be actively sold and continue to further stimulate shares to grow.
